Danian Dai

651 East Dongfeng Road
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.

CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.

Journal: Journal of translational internal medicine

Published: September 02, 2025

TP63 as a modulator of ferroptosis in TP53 mutations glioblastoma.

TP63 as a modulator of ferroptosis in TP53 mutations glioblastoma.

Journal: Cell death & disease

Published: March 04, 2025

crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer.

crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: January 06, 2024

Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer Patients.

Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer Patients.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 30, 2023

Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.

Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.

Journal: Heliyon

Published: October 07, 2023

Genetic and clinical landscape of ER + /PR- breast cancer in China.

Genetic and clinical landscape of ER + /PR- breast cancer in China.

Journal: BMC cancer

Published: April 10, 2023

Analysis of Omics Data Reveals Nucleotide Excision Repair-Related Genes Signature in Highly-Grade Serous Ovarian Cancer to Predict Prognosis.

Analysis of Omics Data Reveals Nucleotide Excision Repair-Related Genes Signature in Highly-Grade Serous Ovarian Cancer to Predict Prognosis.

Journal: Frontiers in cell and developmental biology

Published: February 12, 2022

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer.

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer.

Journal: Frontiers in oncology

Published: August 13, 2020

Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score-matched cohort study.

Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score-matched cohort study.

Journal: Cancer medicine

Published: July 11, 2020

Impact of nonspecific death on overall survival in early-stage epithelial ovarian cancer patients.

Impact of nonspecific death on overall survival in early-stage epithelial ovarian cancer patients.

Journal: Current problems in cancer

Published: May 13, 2020

PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer.

PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer.

Journal: Therapeutic advances in medical oncology

Published: April 27, 2020

Prognostic value of prostaglandin I2 synthase and its correlation with tumor-infiltrating immune cells in lung cancer, ovarian cancer, and gastric cancer.

Prognostic value of prostaglandin I2 synthase and its correlation with tumor-infiltrating immune cells in lung cancer, ovarian cancer, and gastric cancer.

Journal: Aging

Published: December 16, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026